Akaza Research Announces New OpenClinica Enterprise Customers

Akaza Research Announces New OpenClinica Enterprise Customers
The company announces 15 new customer wins in the first half of 2010

Waltham, MA (PRWEB) September 30, 2010
Akaza Research, LLC, the creators of the open source electronic data capture software, OpenClinica, announced today it that in the first half of 2010 the company attracted 15 new OpenClinica Enterprise Edition customers. These customers comprise contract research organizations, pharmaceutical, device, and biotech companies, and academic research organizations.

"We are seeing an acceleration of interest and adoption of OpenClinica Enterprise," said Ben Baumann, Director of Business Development. "The OpenClinica Enterprise Edition is particularly appealing to research organizations that require reliable, professional support, a cost-effective product pricing structure and ability to take control and ownership of the full spectrum of trial development and deployment" he added. "We are already on track to have an extremely positive second half of the year.

OpenClinica is open source software that is distributed in two editions. The OpenClinica Community Edition is freely available under the widely accepted LGPL open source license. The OpenClinica Enterprise Edition is a certified and commercially supported version of the open source technology designed for use in mission critical settings. In many ways, the model is similar to that of RedHat, the purveyor of the open source Linux operating system.

Akaza's new OpenClinica Enterprise Edition customers span 6 different countries: Germany, United Kingdom, Taiwan, France, Canada, and the United States. Mr. Baumann commented that "this geographic diversity of our customer base underscores our ability to deliver effective support worldwide. In addition, the diversity of customer types, encompassing small to large organizations across a spectrum of industries, highlights the widespread applicability of the OpenClinica technology and our commercial open source approach."

About OpenClinica®:
OpenClinica is open source, web-based clinical trials software for electronic data capture (EDC) and clinical data management (CDM). OpenClinica facilitates study protocol configuration, data collection via electronic case report forms (eCRFs), and enables productive clinical trials management. OpenClinica supports HIPAA, 21 CFR Part 11, and other regulatory guidelines and is designed as a standards-based, extensible, and modular platform. The OpenClinica Community (free) and Enterprise (commercial) Editions provide a dramatically lower cost of ownership when compared with alternative proprietary technologies. For more information (including product downloads) visit http://www.openclinica.org or follow @OpenClinica on Twitter.

About Akaza Research®:
Akaza Research is the provider of the leading open source clinical trial software, OpenClinica. Trusted by hundreds of biopharmaceutical companies, contract research organizations, academic, and government organizations worldwide, Akaza's professional open source model brings Open Source Software (OSS) into the mainstream of today's clinical research enterprise. The company provides commercial support to its OpenClinica customers across six continents servicing clinical studies of all types and sizes.

Suggested Articles

What a difference a day makes in biotech.

A report out this week by PwC thinks that biotech could be in for a good year for deals as it sees the momentum from 2019 growing.

A drug developed at Temple restores a mechanism in brain cells that prevents the toxic buildup of the proteins amyloid beta and tau in Alzheimer's.